Clinical Trials in Houston

Showing 10561-10580 of 15,366 trials

Bicuspid Valve Aortopathy Feasibility Study

NCT01920815

In order to determine the effectiveness of medical therapy options to prevent enlargement of the aorta in patients with a bicuspid aortic valve, a randomized study will be planned. This feasibility study will gather accurate data on number needed to screen, changes in medication use over time, and variance of the intended study endpoint.

Bicuspid Aortic Valve

Oregon Health and Science University500 participantsStarted Jul 2013

Los Angeles, California, United States • Denver, Colorado, United States • Atlanta, Georgia, United States +3 more locations

COMPLETEDPhase 1< 1 mile

First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

NCT01971515

This is a Phase 1, first-in-human, open-label, non-randomized, dose escalation, trial to explore the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical activity signals of MSC2363318A.

Solid Tumor

EMD Serono101 participantsStarted Dec 2013

Birmingham, Alabama, United States • Los Angeles, California, United States • San Diego, California, United States +12 more locations

Bicuspid Valve Aortopathy Feasibility Study

First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

Find Trials by Condition in Houston

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Cognition in the Study of Tamoxifen and Raloxifene

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

A-MAV™ Anterior Motion Segment Replacement

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers

An Assessment of the Glider Balloon in Complex Lesions

Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment

Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial

Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment

Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants

A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients